![dual agonist glp-1 glucagon The glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12933-021-01412-5/MediaObjects/12933_2021_1412_Fig1_HTML.png)
![dual agonist glp-1 glucagon The glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology glp-1_analogs [TUSOM | Pharmwiki]](https://ars.els-cdn.com/content/image/1-s2.0-S0006295220303865-ga1.jpg)
![dual agonist glp-1 glucagon The glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology glp-1_analogs [TUSOM | Pharmwiki]](https://www.e-enm.org/upload/thumbnails/enm-2024-1942f1.jpg)
dual agonist glp-1 glucagon
Shipping Estimate
dual agonist glp-1 glucagon The glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology glp-1_analogs [TUSOM | Pharmwiki]
EUR29.79
EUR68.79
Pay in 4 interest-free payments of $7.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
![dual agonist glp-1 glucagon The glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
![dual agonist glp-1 glucagon The glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology glp-1_analogs [TUSOM | Pharmwiki]](https://www.mdpi.com/ijms/ijms-20-04092/article_deploy/html/images/ijms-20-04092-g001-550.jpg)
![dual agonist glp-1 glucagon The glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology glp-1_analogs [TUSOM | Pharmwiki]](https://www.celtarys.com/wp-content/uploads/2026/04/dual-glp-1gip-receptor-agonists-mechanism-of-action-metabolic-implications-and-drug-discovery-advantages-2-1024x507.jpg)
![dual agonist glp-1 glucagon The glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11901-025-00692-9/MediaObjects/11901_2025_692_Fig2_HTML.png)
![dual agonist glp-1 glucagon The glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology glp-1_analogs [TUSOM | Pharmwiki]](https://www.journal-of-hepatology.eu/cms/asset/4c0052b7-563c-442b-acbe-fe1dcb14cd25/gr1.jpg)
